2008
Pathology of an Islet Transplant 2 Years After Transplantation: Evidence for a Nonimmunological Loss
Smith RN, Kent SC, Nagle J, Selig M, Iafrate AJ, Najafian N, Hafler DA, Auchincloss H, Orban T, Cagliero E. Pathology of an Islet Transplant 2 Years After Transplantation: Evidence for a Nonimmunological Loss. Transplantation 2008, 86: 54-62. PMID: 18622278, DOI: 10.1097/tp.0b013e318173a5da.Peer-Reviewed Original ResearchConceptsAllogeneic sensitizationIslet transplantsELISPOT assayRecurrent diabetic nephropathyEvidence of rejectionC-peptide secretionCause of deathNative pancreatic isletsHypertensive strokeIntrahepatic isletsDiabetic nephropathyInsulin independenceAllogeneic isletsAtrophic pancreasPathological findingsImmunological basisEdmonton protocolPortal veinComplete autopsyIslet transplantationImmunohistochemical analysisPortal venulesDrug toxicityEarly changesPhysiological abnormalities
1995
Case 37-1995 — A 6-year-old boy with a rash, meningismus, and diplegia
Cabot R, Scully R, Mark E, McNeely W, McNeely B, Hafler D, Hedley-Whyte E. Case 37-1995 — A 6-year-old boy with a rash, meningismus, and diplegia. New England Journal Of Medicine 1995, 333: 1485-1493. PMID: 7477150, DOI: 10.1056/nejm199511303332208.Peer-Reviewed Original Research